Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Non-platinum combination of gemcitabine in NSCLC.

Favaretto AG.

Ann Oncol. 2006 May;17 Suppl 5:v82-5. Review. No abstract available.

PMID:
16807471
2.

[Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].

Souquet PJ, Gerinière L.

Bull Cancer. 2002 Aug;89 Spec No:S80-4. Review. French.

3.

Non-small-cell lung cancer: which platinum for gemcitabine?

Boni C, Zanelli F, Ambroggi M, Bologna A.

Ann Oncol. 2006 May;17 Suppl 5:v79-81. Review. No abstract available.

PMID:
16807470
4.

Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naïve advanced non-small-cell lung cancer in the era of third-generation agents.

Jiang J, Liang X, Zhou X, Huang R, Chu Z, Zhan Q.

J Cancer Res Clin Oncol. 2013 Jan;139(1):25-38. doi: 10.1007/s00432-012-1294-z. Epub 2012 Aug 5.

PMID:
22864816
5.

[Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?].

Pujol JL, Choma D, Jacot W, Quantin X.

Bull Cancer. 2002 Aug;89 Spec No:S85-90. Review. French.

PMID:
12449036
7.

Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer.

Kim DY, Lee KW, Yun T, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK.

Oncol Rep. 2005 Jul;14(1):207-11.

PMID:
15944791
8.

[Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].

Morere JF.

Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S37-41. French. No abstract available.

PMID:
11924242
9.

[New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].

Mavroudis D.

Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S42-5. Review. French. No abstract available.

PMID:
11924243
10.

Chemoradiation in locally advanced non-small cell lung cancer.

Bonomi P, Shirazi W.

Cancer Treat Res. 2001;105:171-88. Review. No abstract available.

PMID:
11224987
11.

[Gemcitabine].

Takeda K.

Nihon Rinsho. 2002 May;60 Suppl 5:359-65. Review. Japanese. No abstract available.

PMID:
12101689
12.

Lung cancer: therapeutic options for stage IV and recurrent NSCLC.

Calvo AR, Belani CP.

Cancer Treat Res. 2001;105:189-227. Review. No abstract available.

PMID:
11224988
13.
14.

Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.

[No authors listed]

Prescrire Int. 2005 Feb;14(75):16-8.

PMID:
15751170
15.

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.

Greco FA, Gray JR Jr, Thompson DS, Burris HA 3rd, Erland JB, Barton JH Jr, Litchy S, Houston GA, Butts JA, Webb C, Scott C, Hainsworth JD.

Cancer. 2002 Sep 15;95(6):1279-85.

16.

Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative.

Cappuzzo F, Rocha Lima CM, Sherman CA, Green MR.

Oncology (Williston Park). 2000 Jul;14(7 Suppl 4):7-14. Review.

17.

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.

Kosmas C, Tsavaris N, Vadiaka M, Stavroyianni N, Koutras A, Malamos N, Onyenadum A, Rokana S, Polyzos A, Kalofonos HP.

Cancer. 2001 Dec 1;92(11):2902-10.

PMID:
11753965
18.

Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.

Lorusso V, Crucitta E, Panza N, Silvestris N, Guida M, Carpagnano F, Mancarella S, Sambiasi D, De Lena M.

Ann Oncol. 2002 Dec;13(12):1862-7.

PMID:
12453853
19.

Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.

Pallis AG, Syrigos K, Kotsakis A, Karachaliou N, Polyzos A, Chandrinos V, Varthalitis I, Christophyllakis C, Ardavanis A, Vamvakas L, Vardakis N, Saridaki Z, Samonis G, Giassas S, Georgoulias V, Agelaki S.

Clin Lung Cancer. 2011 Mar;12(2):100-5. doi: 10.1016/j.cllc.2011.03.004. Epub 2011 Apr 11.

PMID:
21550556
20.

Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum.

Park YH, Lee JC, Kim CH, Ryoo BY, Kim HT.

Jpn J Clin Oncol. 2004 May;34(5):245-9.

PMID:
15231858

Supplemental Content

Support Center